Kyle Guse
Officer at Atossa Therapeutics, Inc. (ATOS)
Kyle Guse has filed 7 insider reports with the SEC since May 2021, as director at Cerenome, Inc. (CNSY) and officer at Atossa Therapeutics, Inc. (ATOS). The latest filing, on October 1, 2026, reports exercise or conversion of a derivative at Cerenome, Inc. (CNSY).
- Filings
- 7
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where Kyle Guse is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince April 2025 | 1,843 | $0.7024 | Oct 1, 2026 | ||||
| Officer | $1.75 | Feb 28, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Oct 1, 2026CNSYDirector Guse Kyle converted options into 921 shares, increasing direct ownership by 100% to 1,843 unitsForm 4Exercise or conversion of a derivative
- Jul 1, 2026CNSYDirector Guse Kyle converted options into 922 sharesForm 4Exercise or conversion of a derivative
- May 14, 2026CNSYSEC Form 4 filed by Director Guse KyleForm 4Grant or award
- Aug 13, 2025CNSYSEC Form 4 filed by Director Guse KyleForm 4Grant or award
- Apr 18, 2025CNSYNew insider Guse Kyle claimed no ownership of stock in the companyForm 3New insider
- Feb 24, 2022ATOSSEC Form 4 filed by Guse KyleForm 4Grant or award
- May 14, 2021ATOSSEC Form 4 filed by Guse KyleForm 4Grant or award
Compare Kyle Guse with
- Kyle Guse vs Ronald Asbury Andrews1 shared
- Kyle Guse vs Sims Andrew John Hugh MacIntyre1 shared
- Kyle Guse vs Marc H Hedrick1 shared
- Kyle Guse vs An van Es-Johansson1 shared
- Kyle Guse vs Richard J Hawkins1 shared
- Kyle Guse vs Howard Clowes1 shared
Other insiders at the same companies
- Ronald Asbury AndrewsCNSY
- Marc H HedrickCNSY
- An van Es-JohanssonCNSY
- Sims Andrew John Hugh MacIntyreCNSY
- Howard ClowesCNSY
- Richard J HawkinsCNSY
- Richard I SteinhartATOS
- Shu-Chih ChenATOS
- H. Lawrence RemmelATOS
- Jonathan FinnATOS
- Stephen J GalliATOS
- Tessa CiglerATOS
- Eric Joseph DanielsCNSY
- Steven C QuayATOS
- Mark James DanielATOS
- Robert P LenkCNSY
Questions about Kyle Guse
- What is Kyle Guse's role at Atossa Therapeutics, Inc.?
- Kyle Guse reports to the SEC as officer at Atossa Therapeutics, Inc. (ATOS), according to the latest filing on February 28, 2022. Kyle Guse has also filed as director at Cerenome, Inc. (CNSY).
- How many shares does Kyle Guse own?
- After the latest filing that states it, Kyle Guse directly owned 1,843 shares of Cerenome, Inc. (CNSY). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Kyle Guse bought or sold stock recently?
- No open-market purchases or sales by Kyle Guse are on file. The filings report exercise or conversion of a derivative and grant or award.
- How do I get alerts when Kyle Guse files?
- Follow Kyle Guse on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Kyle Guse filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Kyle Guse (SEC CIK 0001566618). Totals count each trade once, skipping amendments whose original is on file, from May 18, 2021 on. View on SEC EDGAR · Get this as JSON